Sensus Healthcare has installed the first SRT-100 System in Ireland at Dublin’s Beacon Hospital. The system will provide a highly efficacious and non-invasive solution to treat the growing numbers of non-melanoma skin cancer patients in Ireland, which is estimated by the Irish Cancer Society to number 12,000 annually and growing. Commenting on the sale, Joe Sardano, chairman and chief executive officer of Sensus Healthcare, said, “We are thrilled to generate our first sale of an SRT System in Ireland and to a leading, technologically savvy facility such as Beacon Hospital. Beacon will serve as an example to the Irish dermato-oncology community of innovation in patient care. We expect that this system will be the first of many placed not only in Ireland, but in the United Kingdom as well.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SRTS:
- Sensus Healthcare to Host Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 3, 2023
- Sensus Healthcare Completes Installation of its First SRT System in Ireland
- Sensus Healthcare Partners with MIS Healthcare to Distribute SRT Systems in the United Kingdom and Ireland
- Sensus Healthcare management to meet virtually with Roth MKM